Jade Biosciences, Inc. (JBIO) bonds
JBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$15.40+0.06 (+0.42%)
Close on Nov 17, 2026Market cap $979.40MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Jade Biosciences reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Jade Biosciences's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Amount issued |
|---|---|---|
| Purchase Agreement Convertible | – | $0 |
| Purchase Agreement | 12.00% | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?